← Leaderboards
Brad Fortune
Legacy Emanuel Hospital And Health Center
$9,661,225
Attributed
$19,530,409
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,530,409 · 8
By mechanism
R01$11,864,203 · 5
U24$6,937,730 · 1
R21$728,476 · 2
Top collaborators
- Yvonne Ou13 shared
- Benjamin M Sivyer12 shared
- Jason Stephen Meyer8 shared
- Adriana Di Polo6 shared
- Gareth R Howell4 shared
Most similar at Legacy Emanuel Hospital And Health Center
Same institution · by research overlap
- Shaban Demirel$1,833,583
Others in their field
Top investigators on “Glaucoma”
- Rohit Varma · University Of Southern California$58,233,961
- Janey L Wiggs · Massachusetts Eye And Ear Infirmary$36,083,461
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$27,740,623
- Linda M Zangwill · University Of California San Diego$23,025,291
- Robert N Weinreb · University Of California, San Diego$21,784,031
Research focus
GlaucomaRetinal Ganglion CellsRetinaCell InjuryBlindnessCellsOptic NerveNonhuman PrimateExperimental ModelsNeuronsResearch PersonnelAxonVisionSight RestorationElectrophysiology (Science)In VivoAnatomyRepairedInnovationTranslationsRetinal NeuronPhysiologic Intraocular PressureFunctional DisorderStructure
Grant awards (31)
Interpericyte tunneling nanotubes as new therapeutic targets for neurovascular recovery and vision restoration in glaucoma.$2,674,763
R01 · FY2025 · EY
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma$1,283,906
U24 · FY2025 · EY
Retinal circuit disassembly in primate glaucoma$725,589
R01 · FY2025 · EY
Retinal circuit disassembly in primate glaucoma$54,051
R01 · FY2025 · EY
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma$1,328,663
U24 · FY2024 · EY
Retinal circuit disassembly in primate glaucoma$726,057
R01 · FY2024 · EY
Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling.$507,148
R01 · FY2024 · EY
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma$145,254
U24 · FY2024 · EY
Retinal circuit disassembly in primate glaucoma$96,067
R01 · FY2024 · EY
Retinal circuit disassembly in primate glaucoma - Diversity Supplement$42,854
R01 · FY2024 · EY
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma$1,339,355
U24 · FY2023 · EY
Retinal circuit disassembly in primate glaucoma$756,073
R01 · FY2023 · EY
Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling.$609,416
R01 · FY2023 · EY
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma$93,412
U24 · FY2023 · EY
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma$1,353,535
U24 · FY2022 · EY
Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling.$591,134
R01 · FY2022 · EY
Advancing OCT evaluation to reveal early-stage changes in glaucoma$529,495
R01 · FY2022 · EY · contact PI
Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma$1,393,605
U24 · FY2021 · EY
Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling.$591,133
R01 · FY2021 · EY
Advancing OCT evaluation to reveal early-stage changes in glaucoma$530,254
R01 · FY2021 · EY · contact PI
Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling.$607,276
R01 · FY2020 · EY
Advancing OCT evaluation to reveal early-stage changes in glaucoma$543,351
R01 · FY2020 · EY · contact PI
Advancing OCT evaluation to reveal early-stage changes in glaucoma$568,884
R01 · FY2019 · EY · contact PI
Targeting the diversity of retinal ganglion cells for replacement therapy$345,976
R21 · FY2019 · EY
Axonal cytoskeletal changes in experimental glaucoma$371,250
R01 · FY2014 · EY · contact PI
Axonal cytoskeletal changes in experimental glaucoma$327,175
R01 · FY2012 · EY · contact PI
Imaging retinal astrocytes, ganglion cells and axonal transport in vivo$191,250
R21 · FY2012 · EY · contact PI
Axonal cytoskeletal changes in experimental glaucoma$327,175
R01 · FY2011 · EY · contact PI
Imaging retinal astrocytes, ganglion cells and axonal transport in vivo$191,250
R21 · FY2011 · EY · contact PI
Axonal cytoskeletal changes in experimental glaucoma$340,808
R01 · FY2010 · EY · contact PI
Axonal cytoskeletal changes in experimental glaucoma$344,250
R01 · FY2009 · EY · contact PI